Combination Therapies (e.g., Liposomal Amphotericin B + Miltefosine)

Treatment for Visceral leishmaniasis

Effectiveness
98%
Safety Score
55%
Clinical Trials
25
Participants
2.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
55
DangerousModerateSafe
Treatment Details
0
Combination Therapies (e.g., Liposomal Amphotericin B + Miltefosine) Outcomes

for Visceral leishmaniasis

Efficacy Outcomes
Overall Effectiveness
+98%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov